---
figid: PMC7493839__12935_2020_1546_Fig3_HTML
figlink: pmc/articles/PMC7493839/figure/Fig3/
number: Fig. 3
caption: Application of CRISPR-Cas9 in construction of TCR and CAR T-cells. a CRISPR-Cas9
  is used for the creation of allogeneic T-cells by depletion of endogenous TCR and
  MHC class I genes through the NHEJ pathway. b Inhibition of immune checkpoint pathways
  such as PD-1, CTLA4, LAG3, TIM3, and FAS is accessible through the employment of
  CRISPR-Cas9 to disrupt the related receptors on T-cells. c Installation of transgenic
  TCR or CAR into T-cells through HDR-mediated knock-in potential of CRISPR-Cas9.
  TCR and CAR can be inserted in between of a locus of interest. For instance, the
  introduction of TCR or CAR among TRAC locus in order to simultaneous knockout of
  endogenous TCR and establishment of recombinant TCR or CAR leads to homogenous expression
  of cassette and also the elimination of mutation probability, which is common among
  vector integration methods. d Loss of function screening is another application
  of CRISPR, in which effect of T-cell function on cancer immunotherapy in presence
  or absence of a gene is investigated and the results may use for development of
  further immunotherapeutic approaches
pmcid: PMC7493839
papertitle: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer
  immunotherapy.
reftext: Seyed Mohammad Miri, et al. Cancer Cell Int. 2020;20:456.
pmc_ranked_result_index: '77137'
pathway_score: 0.5012791
filename: 12935_2020_1546_Fig3_HTML.jpg
figtitle: Application of CRISPR-Cas9 in construction of TCR and CAR T-cells
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7493839__12935_2020_1546_Fig3_HTML.html
  '@type': Dataset
  description: Application of CRISPR-Cas9 in construction of TCR and CAR T-cells.
    a CRISPR-Cas9 is used for the creation of allogeneic T-cells by depletion of endogenous
    TCR and MHC class I genes through the NHEJ pathway. b Inhibition of immune checkpoint
    pathways such as PD-1, CTLA4, LAG3, TIM3, and FAS is accessible through the employment
    of CRISPR-Cas9 to disrupt the related receptors on T-cells. c Installation of
    transgenic TCR or CAR into T-cells through HDR-mediated knock-in potential of
    CRISPR-Cas9. TCR and CAR can be inserted in between of a locus of interest. For
    instance, the introduction of TCR or CAR among TRAC locus in order to simultaneous
    knockout of endogenous TCR and establishment of recombinant TCR or CAR leads to
    homogenous expression of cassette and also the elimination of mutation probability,
    which is common among vector integration methods. d Loss of function screening
    is another application of CRISPR, in which effect of T-cell function on cancer
    immunotherapy in presence or absence of a gene is investigated and the results
    may use for development of further immunotherapeutic approaches
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRA
  - TRB
  - TRD
  - TRG
  - LAG3
  - PDCD1
  - FAS
  - HAVCR2
  - CTLA4
  - MARVELD2
  - GATA3
  - IL21
  - B2M
  - TCR
genes:
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: LÁG3
  symbol: LAG3
  source: hgnc_symbol
  hgnc_symbol: LAG3
  entrez: '3902'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: FAS.
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: TIM3.
  symbol: TIM3
  source: hgnc_alias_symbol
  hgnc_symbol: HAVCR2
  entrez: '84868'
- word: LAG3.
  symbol: LAG3
  source: hgnc_symbol
  hgnc_symbol: LAG3
  entrez: '3902'
- word: CTLA4.
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TRIC,
  symbol: TRIC
  source: hgnc_alias_symbol
  hgnc_symbol: MARVELD2
  entrez: '153562'
- word: TRAC,TRIC,
  symbol: TRIC
  source: hgnc_alias_symbol
  hgnc_symbol: MARVELD2
  entrez: '153562'
- word: HDR
  symbol: HDR
  source: hgnc_alias_symbol
  hgnc_symbol: GATA3
  entrez: '2625'
- word: LAG3
  symbol: LAG3
  source: hgnc_symbol
  hgnc_symbol: LAG3
  entrez: '3902'
- word: CTLA4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: TIM3
  symbol: TIM3
  source: hgnc_alias_symbol
  hgnc_symbol: HAVCR2
  entrez: '84868'
- word: FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: IL21
  symbol: IL21
  source: hgnc_symbol
  hgnc_symbol: IL21
  entrez: '59067'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: B2m
  symbol: B2M
  source: hgnc_symbol
  hgnc_symbol: B2M
  entrez: '567'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
diseases: []
---
